Pharmaids (PHARMAID) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
194.5M
Gross Profit
70.4M
36.22%
Operating Income
-152.0M
-78.15%
Net Income
-135.1M
-69.44%
Balance Sheet Metrics
Total Assets
1.2B
Total Liabilities
648.1M
Shareholders Equity
550.4M
Debt to Equity
1.18
Cash Flow Metrics
Operating Cash Flow
-278.1M
Free Cash Flow
-264.7M
Revenue & Profitability Trend
Pharmaids Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 194.5M | 146.0M | 0 | 39.4M | 85.5M |
| Cost of Goods Sold | 124.0M | 129.0M | 8.9M | 35.7M | 81.6M |
| Gross Profit | 70.4M | 17.0M | -8.9M | 3.7M | 3.9M |
| Operating Expenses | 66.4M | 48.2M | 76.9M | 1.1M | 1.5M |
| Operating Income | -152.0M | -140.1M | -99.0M | 1.3M | 732.0K |
| Pre-tax Income | -172.8M | -156.2M | -99.1M | 1.4M | 884.3K |
| Income Tax | -37.7M | -37.8M | -23.5M | -48.8K | -48.8K |
| Net Income | -135.1M | -118.4M | -75.6M | 1.5M | 933.1K |
| EPS (Diluted) | - | -₹3.51 | -₹5.86 | ₹0.14 | ₹0.09 |
Income Statement Trend
Pharmaids Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 223.1M | 135.3M | 183.2M | 26.7M | 8.6M |
| Non-Current Assets | 975.5M | 778.1M | 62.7M | 84.4M | 82.6M |
| Total Assets | 1.2B | 913.4M | 245.8M | 111.1M | 91.2M |
| Liabilities | |||||
| Current Liabilities | 287.1M | 115.8M | 21.2M | 24.4M | 5.9M |
| Non-Current Liabilities | 361.0M | 92.7M | -1.0K | 0 | 0 |
| Total Liabilities | 648.1M | 208.4M | 21.2M | 24.4M | 5.9M |
| Equity | |||||
| Total Shareholders Equity | 550.4M | 705.0M | 224.6M | 86.7M | 85.3M |
Balance Sheet Composition
Pharmaids Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -172.8M | -156.2M | -99.1M | 1.4M | 884.3K |
| Operating Cash Flow | -278.1M | -131.9M | -36.4M | -1.2M | -1.3M |
| Investing Activities | |||||
| Capital Expenditures | -122.6M | -227.2M | -16.7M | 0 | -15.0K |
| Investing Cash Flow | -122.6M | -752.0M | -82.1M | 4.7M | 4.5M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 258.2M | 795.6M | 213.1M | 0 | 0 |
| Free Cash Flow | -264.7M | -334.8M | -56.9M | -2.6M | 4.0M |
Cash Flow Trend
Pharmaids Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
2,023.33
Price to Book
6.92
Price to Sales
10.63
Profitability Ratios
Profit Margin
-55.41%
Operating Margin
-93.48%
Return on Equity
-21.52%
Return on Assets
-8.99%
Financial Health
Current Ratio
0.78
Debt to Equity
70.81
Beta
0.32
Per Share Data
EPS (TTM)
-₹3.05
Book Value per Share
₹8.36
Revenue per Share
₹5.50
Financial data is updated regularly. All figures are in the company's reporting currency.